Vincent Venditto, PhD

Vincent Venditto is no longer active with the UCSF-Gladstone CFAR.

  • Postdoctoral Scholar, UCSF School of Pharmacy

Displaying 1 - 15 of 15

  1. Julien O, Kampmann M, Bassik MC, Zorn JA, Venditto VJ, Shimbo K, Agard NJ, Shimada K, Rheingold AL, Stockwell BR, Weissman JS, Wells JA. Unraveling the mechanism of cell death induced by chemical fibrils. Nat Chem Biol. 2014 Nov; 10(11):969-76. View on Pubmed
  2. Venditto VJ, Dolor A, Kohli A, Salentinig S, Boyd BJ, Szoka FC. Sulfated quaternary amine lipids: a new class of inverse charge zwitterlipids. Chem Commun (Camb). 2014 Aug 21; 50(65):9109-11. View on Pubmed
  3. Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits. Clin Vaccine Immunol. 2014 Aug; 21(8):1086-93. View on Pubmed
  4. Kohli AG, Kierstead PH, Venditto VJ, Walsh CL, Szoka FC. Designer lipids for drug delivery: from heads to tails. J Control Release. 2014 Sep 28; 190:274-87. View on Pubmed
  5. Jameson DL, Field T, Schmidt MR, DeStefano AK, Stiteler CJ, Venditto VJ, Krovic B, Hoffman CM, Ondisco MT, Belowich ME. Application of crystallization-induced asymmetric transformation to a general, scalable method for the resolution of 2,8-disubstituted Tröger's base derivatives. J Org Chem. 2013 Nov 15; 78(22):11590-6. View on Pubmed
  6. Shetlar MD, Hom K, Venditto VJ. Photohydrate-mediated reactions of uridine, 2'-deoxyuridine and 2'-deoxycytidine with amines at near neutral pH. Photochem Photobiol. 2013 Jul-Aug; 89(4):869-77. View on Pubmed
  7. Venditto VJ, Watson DS, Motion M, Montefiori D, Szoka FC. Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination. Clin Vaccine Immunol. 2013 Jan; 20(1):39-45. View on Pubmed
  8. Venditto VJ, Szoka FC. Cancer nanomedicines: so many papers and so few drugs! Adv Drug Deliv Rev. 2013 Jan; 65(1):80-8. View on Pubmed
  9. Watson DS, Platt VM, Cao L, Venditto VJ, Szoka FC. Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice. Clin Vaccine Immunol. 2011 Feb; 18(2):289-97. View on Pubmed
  10. Lim J, Venditto VJ, Simanek EE. Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups. Bioorg Med Chem. 2010 Aug 1; 18(15):5749-53. View on Pubmed
  11. Venditto VJ, Simanek EE. Cancer therapies utilizing the camptothecins: a review of the in vivo literature. Mol Pharm. 2010 Apr 5; 7(2):307-49. View on Pubmed
  12. Venditto VJ, Allred K, Allred CD, Simanek EE. Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles. Chem Commun (Camb). 2009 Oct 7; (37):5541-2. View on Pubmed
  13. Torti SV, Ma R, Venditto VJ, Torti FM, Planalp RP, Brechbiel MW. Preliminary evaluation of the cytotoxicity of a series of tris-2-aminoethylamine (Tren) based hexadentate heterocyclic donor agents. Bioorg Med Chem. 2005 Nov 1; 13(21):5961-7. View on Pubmed
  14. Venditto VJ, Regino CA, Brechbiel MW. PAMAM dendrimer based macromolecules as improved contrast agents. Mol Pharm. 2005 Jul-Aug; 2(4):302-11. View on Pubmed
  15. Camphausen K, Sproull M, Tantama S, Venditto V, Sankineni S, Scott T, Brechbiel MW. Evaluation of chelating agents as anti-angiogenic therapy through copper chelation. Bioorg Med Chem. 2004 Oct 1; 12(19):5133-40. View on Pubmed